lutetium lu 177 vipivotide tetraxetan,cabazitaxel
emcure,sanofi,novartis
['crpc', 'cabazitaxel', 'prostate', 'therap ']
long term follow-up of #lupsma vs #cabazitaxel in #mcrpc #prostatecancer presented by #asco22 #therap interesting if underpowered analysis with stated caveats supporting lupsma. a subtle reminder though that cabzitaxel is an effective &amp; likely underused option 
Clinical researcher focused on #ProstateCancer & #immunotherapy. Views are my own & do not represent the National Cancer Institute